These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38185042)

  • 1. Claudins and hepatocellular carcinoma.
    Wang W; Zhou Y; Li W; Quan C; Li Y
    Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudins and Gastric Cancer: An Overview.
    Hashimoto I; Oshima T
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.
    Suh Y; Yoon CH; Kim RK; Lim EJ; Oh YS; Hwang SG; An S; Yoon G; Gye MC; Yi JM; Kim MJ; Lee SJ
    Oncogene; 2013 Oct; 32(41):4873-82. PubMed ID: 23160379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
    Zhou S; Piao X; Wang C; Wang R; Song Z
    Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
    Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
    Front Genet; 2022; 13():783016. PubMed ID: 35281827
    [No Abstract]   [Full Text] [Related]  

  • 6. Claudin expression in breast cancer: high or low, what to expect?
    Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
    Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
    Sun L; Feng L; Cui J
    Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
    Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
    PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
    Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
    Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
    Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
    J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
    Jia H; Chai X; Li S; Wu D; Fan Z
    Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Saviano A; Roehlen N; Baumert TF
    Semin Liver Dis; 2024 May; 44(2):180-190. PubMed ID: 38648796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double mutation of claudin-1 and claudin-3 causes alopecia in infant mice.
    Suzuki K; Yamaga K; Tokumasu R; Katsuno T; Tanaka H; Chiba S; Yagi T; Katayama I; Tamura A; Murota H; Tsukita S
    Ann N Y Acad Sci; 2023 May; 1523(1):51-61. PubMed ID: 37002535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mRNA of claudins is expressed in the endolymphatic sac epithelia.
    Matsubara A; Miyashita T; Mori T; Akiyama K; Inamoto R; Mori N
    Auris Nasus Larynx; 2012 Aug; 39(4):361-4. PubMed ID: 21871748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis.
    Arabzadeh A; Troy TC; Turksen K
    BMC Cancer; 2007 Oct; 7():196. PubMed ID: 17945025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
    Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudins and pathogenesis of viral infection.
    Tawar RG; Colpitts CC; Lupberger J; El-Saghire H; Zeisel MB; Baumert TF
    Semin Cell Dev Biol; 2015 Jun; 42():39-46. PubMed ID: 25960372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
    Uthayanan L; El-Bahrawy M
    J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polar and charged extracellular residues conserved among barrier-forming claudins contribute to tight junction strand formation.
    Piontek A; Rossa J; Protze J; Wolburg H; Hempel C; Günzel D; Krause G; Piontek J
    Ann N Y Acad Sci; 2017 Jun; 1397(1):143-156. PubMed ID: 28415153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.